Status:
UNKNOWN
Determination of Citrate Clearance Used in Regional Anticoagulation of Continuous Venous Hemofiltration Circuits
Lead Sponsor:
Dr David DE BELS
Conditions:
Dialysis
Eligibility:
All Genders
18+ years
Brief Summary
Citrate anticoagulation is becoming the gold standard in dialysis in intensive care units. It is now accepted that citrate prolongs the life of filters with a lower risk of bleeding. However, the man...
Eligibility Criteria
Inclusion
- \- Intensive care dialysis patients (Continuous Venous Hemofiltration with citrate).
Exclusion
- \- None
Key Trial Info
Start Date :
September 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04024007
Start Date
September 1 2019
End Date
December 1 2023
Last Update
March 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Brugmann
Brussels, Belgium, 1020